Post
-
ACR, EULAR preview release of new classification criteria for vasculitis
Peter Grayson, MD, MSc, and Raashid Luqmani, MBBS, DM, FRCP, provided an overview of the new ACR/EULAR classification criteria for vasculitis, the ACR’s first update to the classification criteria for vasculitis since 1990.
-
Late-breaking abstracts reinforce need for COVID-19 vaccination, boosters for immunocompromised patients
Of the six late-breaking abstracts presented at ACR Convergence 2021, three highlighted the importance of COVID-19 vaccination and booster shots for immunocompromised patients.
-
Plenary III: Secukinumab shows positive results in children with active enthesitis-related arthritis, juvenile psoriatic arthritis
Investigators presented findings from six significant studies, including the JUNIPERA trial, during Plenary III on Monday, Nov. 8.
-
Researchers working to expand role of microbiome in rheumatic diseases
Yasmine Belkaid, PhD, Renuka Nayak, MD, PhD, and Jose U. Scher, MD, discussed a growing body of research designed to harness the microbiota communities that live on our exposed surfaces, from the gut to the skin and eyes.
-
VEXAS syndrome illustrates need for new approach to define complex diseases
Dan Kastner, MD, PhD, described the unique, genotype-first strategy that researchers used to identify and define VEXAS syndrome, a complex rheumatic disease that had not been defined by conventional research approaches.
-
New ACR leadership confirmed at 2021 Business Meeting
Kenneth G. Saag, MD, MSc, became the 85th ACR President on Tuesday, Nov. 9, at the annual ACR Business Meeting. The Board of Directors was also confirmed.
-
Debriefs and Poster Tours extend live programming into February
Beginning December 10, the ACR Convergence virtual platform will be updated nearly every Friday with additional live learning opportunities.